6.80
price up icon1.04%   0.07
after-market Handel nachbörslich: 6.80
loading

Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
12.18%
66.77
59.52 51.44 49.25 45.85
Operating Income/Loss
12.18%
-66.77
-59.52 -51.44 -49.25 -45.85
Income/Loss From Continuing Operations Before Tax
14.49%
-62.41
-54.51 -46.15 -45.86 -42.39
Income/Loss From Continuing Operations After Tax
14.49%
-62.41
-54.51 -46.15 -45.86 -42.39
Net Income/Loss
14.49%
-62.41
-54.51 -46.15 -45.86 -42.39
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4,046%
86.68
2.0908 85.95 74.96 71.97
Diluted Average Shares
4,046%
86.68
2.0908 85.95 74.96 71.97
Basic Earnings Per Share
12.50%
-0.72
-0.64 -0.54 -0.61 -0.59
Diluted Earnings Per Share
12.50%
-0.72
-0.64 -0.54 -0.61 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):